Jess Hadley, community pharmacist and Professional Officer at PDL[/caption]
Peter Guthrey, Senior Pharmacist – Strategic Policy at PSA[/caption]
Professor Margie Danchin[/caption]
Dr Peter Tenni[/caption]
How should we deprescribe gabapentinoids, according to the Maudsley Deprescribing Guidelines[/caption]
Women and heart health
Cardiovascular disease is the largest cause of death in Australian women and pharmacists can help them check their heart health and manage their risk...
Burgeoning pharmacy leader named PSA ECP of the Year
South Australia's Dr Jacinta Johnson MPS has been named PSA's Early Career Pharmacist of the Year in recognition of the leadership she has provided...
Is combined NRT therapy the best bet for smoking cessation?
Groundbreaking new research has found that current smokers are three times more likely to die from cardiovascular disease (CVD), but these risks greatly decrease...
Opioid therapy challenges in rural Australia
For more than a decade, healthcare workers in rural and remote areas have been aware of the rising incidence of non-prescribed opioid medicines use....
Pharmacists deliver on all fronts
Two PSA members will join the Deputy Chief Medical Officer Professor Michael Kidd on the National Medicines Policy Review Committee, due to start work next month.
Dry skin management
Pharmacists can advise patients and demonstrate the use of emollients for the treatment of dry skin.
A consensus statement on the management of dry skin...
